155 related articles for article (PubMed ID: 25339018)
41. Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis.
Yang L; Li N; Wang S; Kong Y; Tang H; Xie X; Xie X
Asian Pac J Cancer Prev; 2014; 15(12):4823-7. PubMed ID: 24998547
[TBL] [Abstract][Full Text] [Related]
42. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
43. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Qiu LX; Wang Y; Xia ZG; Xi B; Mao C; Wang JL; Wang BY; Lv FF; Wu XH; Hu LQ
Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
[TBL] [Abstract][Full Text] [Related]
44. Meta-analysis on the associations of TLR2 gene polymorphisms with pulmonary tuberculosis susceptibility among Asian populations.
Wang JJ; Xia X; Tang SD; Wang J; Deng XZ; Zhang Y; Yue M
PLoS One; 2013; 8(10):e75090. PubMed ID: 24124467
[TBL] [Abstract][Full Text] [Related]
45. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
46. Lack of association of three common polymorphisms in toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and Arg753Gln with cancer risk: a meta-analysis.
Yang X; Wang XX; Qiu MT; Hu JW; Yin R; Xu L; Zhang Q
Asian Pac J Cancer Prev; 2013; 14(10):5871-6. PubMed ID: 24289592
[TBL] [Abstract][Full Text] [Related]
47. Toll-Like Receptor (TLR)-9 rs352140 Polymorphism is an Immunopathology Protective Factor in Parkinson's Disease in the Northern Iranian Population.
Miri NS; Saadat P; Azadmehr A; Oladnabi M; Daraei A
Iran J Immunol; 2020 Dec; 17(4):313-323. PubMed ID: 33382388
[TBL] [Abstract][Full Text] [Related]
48. G894T and 4a/b polymorphisms of NOS3 gene are not associated with cancer risk: a meta-analysis.
Haque S; Mandal RK; Akhter N; Panda AK; Hussain A; Khan S; Lohani M
Asian Pac J Cancer Prev; 2015; 16(7):2929-37. PubMed ID: 25854385
[TBL] [Abstract][Full Text] [Related]
49. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
50. Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis.
Chen Z; Wang SH; Zhou J; Wu T; Li J
J Cancer Res Ther; 2015; 11(4):810-7. PubMed ID: 26881523
[TBL] [Abstract][Full Text] [Related]
51. Associations of toll-like receptor 4 and 2 gene polymorphisms with susceptibility to ankylosing spondylitis: A meta-analysis.
Gao S; Zhang J; Xu T; Xun C; Cao R; Guo H; Liang W; Sheng W
Int J Immunogenet; 2021 Apr; 48(2):219-228. PubMed ID: 33369094
[TBL] [Abstract][Full Text] [Related]
52. Non-association of IL-16 rs4778889 T/C polymorphism with cancer risk in Asians: a meta-analysis.
Xu LL; Song ZC; Shang K; Zhao LQ; Zhu ZS
Asian Pac J Cancer Prev; 2014; 15(2):803-5. PubMed ID: 24568499
[TBL] [Abstract][Full Text] [Related]
53. Meta-analysis of 5-hydroxytryptamine type 2A receptor polymorphisms and migraine susceptibility.
Peng JM; Yu YJ; Su LD; Luo X
Int J Neurosci; 2014 Dec; 124(12):882-9. PubMed ID: 25019276
[TBL] [Abstract][Full Text] [Related]
54. Association between rs1862513 and rs3745367 Genetic Polymorphisms of Resistin and Risk of Cancer: A Meta-Analysis.
Hashemi M; Bahari G; Tabasi F; Moazeni-Roodi A; Ghavami S
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2709-2716. PubMed ID: 30360595
[TBL] [Abstract][Full Text] [Related]
55. Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.
Qin TT; Chen T; Zhang Q; Du HN; Shu YQ; Luo K; Zhu LJ
Biomed Pharmacother; 2014 Sep; 68(7):905-10. PubMed ID: 25194442
[TBL] [Abstract][Full Text] [Related]
56. Association between VDR polymorphisms and breast cancer: an updated and comparative meta-analysis of crude and adjusted odd ratios.
Huang QQ; Liao YY; Ye XH; Fu JJ; Chen SD
Asian Pac J Cancer Prev; 2014; 15(2):847-53. PubMed ID: 24568506
[TBL] [Abstract][Full Text] [Related]
57. Association between STAT3 polymorphisms and cancer risk: a meta-analysis.
Yan R; Lin F; Hu C; Tong S
Mol Genet Genomics; 2015 Dec; 290(6):2261-70. PubMed ID: 26063618
[TBL] [Abstract][Full Text] [Related]
58. Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.
Wan GX; Chen P; Yu XJ; Di QS; Yu YD; Lei JH; Tai YY; Cao FJ
Int J Clin Exp Med; 2015; 8(3):3935-45. PubMed ID: 26064295
[TBL] [Abstract][Full Text] [Related]
59. Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk.
Ke P; Wu ZD; Wen HS; Ying MX; Long HC; Qing LG
Asian Pac J Cancer Prev; 2013; 14(4):2269-72. PubMed ID: 23725125
[TBL] [Abstract][Full Text] [Related]
60. Relationship Between CASP9 and CASP10 Gene Polymorphisms and Cancer Susceptibility: Evidence from an Updated Meta-analysis.
Sargazi S; Abghari AZ; Sarani H; Sheervalilou R; Mirinejad S; Saravani R; Eskandari E
Appl Biochem Biotechnol; 2021 Dec; 193(12):4172-4196. PubMed ID: 34463927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
